News

Eyal Zimlichman, Sheba Medical Center’s Chief Medical Officer and Chief Innovation Officer, discussed innovations to address the COVID-19 pandemic at the May, 2021 CHDS seminar. Zimlichman presented

The “efficiency” of a program depends on how the benefits and costs are distributed in a population and on the units in which benefits and costs are measured, the so-called “numeraire.” This

With COVID-19 and beyond, advancing toward universal health care will be more difficult for many countries. Local national priority setting is urgently required to provide health

CHDS’ Ankur Pandya and colleagues discuss the distinction between no-value care and low-value care in a recently published article, “Responding to Health-Improving but Cost-Ineffective Care,”

Dr. Mohammad Jalali (‘MJ’), assistant professor at Harvard Medical School and research affiliate with MIT Sloan School, presented his research on modeling the opioid epidemic in the

CHDS faculty Lisa A. Robinson and James K. Hammitt are leading an online professional development workshop, “Benefit-Cost Analysis in Low- and Middle-Income Countries.” The

The Society for Benefit-Cost Analysis (SBCA) honored CHDS faculty James K. Hammitt with its highest award, the Outstanding Achievement Award, in March, 2021. Hammitt has published over 180 peer-reviewed

One year into the COVID-19 pandemic, mathematical models continue to be used to make sense of the epidemic and shape public policy decision-making. Researchers at Harvard T.H. Chan

CHDS faculty Thomas Gaziano and MGH clinical researcher, Mark Siedner were awarded a grant to study blood pressure control in South Africa. “Implementation of a

Dr. Karen Hofman, from the Wits School of Public Health at the University of Witwatersrand, Johannesburg, South Africa, presented her research on sugary beverage taxes at the March CHDS seminar.